Atlas Trials

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT06435858 · RECRUITING

Trial details

NCT number
NCT06435858
Sponsor
Cantonal Hospital Graubuenden
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Autosomal Dominant Polycystic Kidney Disease
Start date
2024-09-01
Primary completion
2025-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.